GLP-1 Microdosing: What It Is, What the Evidence Says, and Who Itโs For
No regulator has approved a GLP-1 microdose protocol. One randomized dose-ranging trial still tested those low doses. Here is what it found and what it did not.
Author: Biana Borchenko
-
-
Wegovy vs Zepbound: Which GLP-1 Is Right for You?
Zepbound is tirzepatide, Wegovy is semaglutide. The head to head trial favored tirzepatide, but the two FDA labels now cover different conditions. Here is how to choose.
-
Sermorelin Dosage and Side Effects: A Physician-Reviewed Guide
Sermorelin has never had an FDA-approved adult dose. The only labeled doses were pediatric and diagnostic. Here is what the research actually used and what it found.
-
ARA-290 (Cibinetide): Neuropathy Research, Dosing and What to Expect
ARA-290 has five published human trials, more than most peptides sold online. Nerve fiber density improved; pain did not separate from placebo. Here is what the research actually shows.
-
Melanotan II: What the Research Actually Shows About Safety and Risk
Melanotan II has never been approved by any regulator. Its efficacy evidence is one 1996 pilot study in three men; its safety record is roughly twenty case reports. What that actually means, with no dosing protocol.
-
Selank Peptide: What the Research Actually Says
Selank is a synthetic seven-amino-acid peptide developed in Russia and studied as an anxiolytic. Here is what the published research shows and what remains unproven.
-
MK-677 (Ibutamoren): Not a Peptide, and What the Trials Actually Found
MK-677 (ibutamoren) is not a peptide but a small synthetic molecule that activates the ghrelin receptor. Here is what the clinical trials actually found and what that means for you.
-
IV Therapy for Jet Lag: What It Actually Fixes (and What Resets Your Body Clock)
An IV drip will not reset your body clock. Here is what a travel-recovery IV can restore after a long flight, and what actually helps your body clock adjust.
-
Tesamorelin Dosage Guide: 1.28 mg, 1.4 mg or 2 mg? What the Label Actually Says
The FDA-approved tesamorelin dose depends on which formulation you have, and many online guides still quote a discontinued one. Here is what the current Egrifta WR label actually says.
-
EBOO vs Dialysis vs Plasmapheresis: What Each One Actually Does (and Where EBO2 Fits)
EBOO is not dialysis and not plasma exchange. What each procedure removes, what the evidence shows, and why EBO2 has no literature at all.
-
GHK-Cu Dosage Guide: What the Evidence Actually Shows for Injection, Topical and Cycling
What the published evidence actually shows about GHK-Cu dosing, and the 2026 FDA status by route.
-
EBOO Therapy Side Effects, Safety & Insurance Coverage: What to Know
EBOO therapy side effects, who should avoid it, and why insurance does not cover EBOO in the US.
